ANI Pharmaceuticals
ANIP
#5252
Rank
A$1.79 B
Marketcap
$85.45
Share price
1.07%
Change (1 day)
9.34%
Change (1 year)

P/E ratio for ANI Pharmaceuticals (ANIP)

P/E ratio as of November 2024 (TTM): -120

According to ANI Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -119.819. At the end of 2022 the company had a P/E ratio of -13.2.

P/E ratio history for ANI Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-13.2-6.66%
2021-14.2-8.21%
2020-15.4-112.52%
2019123261.64%
201834.1-104.76%
2017-716-501.65%
2016178429.39%
201533.752.9%
201422.0-766.96%
2013-3.30246.37%
2012-0.95351.07%
2011-0.9434-59.06%
2010-2.30122.5%
2009-1.04-34.75%
2008-1.59-87.4%
2007-12.6-154.58%
200623.1-416.21%
2005-7.30-6.75%
2004-7.834%
2003-7.5323.58%
2002-6.09-69.19%
2001-19.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-88.3-26.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-1.95-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.52-92.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
13.5-111.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0271-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-11.2-90.69%๐Ÿ‡บ๐Ÿ‡ธ USA
121-201.18%๐Ÿ‡บ๐Ÿ‡ธ USA
27.7-123.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
48.4-140.41%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.